HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Thromboprophylaxis compliance at forefront of oncology discussions
• ASCO to help provide oncology training in developing nations
• Comprehensive screening guidelines issued for breast, cervical and colorectal cancers
• LAP2: Laparoscopy safe for staging in patients with uterine cancer
• New approach needed for breast and prostate cancer screening
• Should VTE prophylaxis be administered to inpatients and outpatients with cancer?
• Frederick Banting discovered insulin in 1921
• Can we save money by spending more? A case for cancer research Douglas Yee, MD
• Onc talk: Helping patients know their diseases inside and out William Wood, MD
• Cediranib showed anticancer activity in recurrent epithelial ovarian, fallopian tube and peritoneal cancer
• Combination antiretroviral therapy may prove most beneficial by maintaining higher CD4 counts
• Contralateral breast cancer risk may depend on age and BRCA gene affected
• Cytotoxic T lymphocytes provided long- term protection from EBV–positive lymphoma
• Distribution of body fat a factor in assessing risk for VTE
• Features of breast lobule predicted breast cancer risk
• High-intensity CRC screening intervention not cost-effective in small practices
• Local excision alone enough for highly selected patients with low/intermediate-grade DCIS
• Suicide ideation increased among adult survivors of childhood cancer
• Lapatinib, letrozole increased PFS for HR+, HER2+ metastatic breast cancer
• Opioid-induced adverse effects and their management EdenMae Camarines, PharmD, BCPS